Summary of Tenet Healthcare Conference Call Company Overview - **Company**: Tenet Healthcare (THC) - **Industry**: Healthcare Facilities and Managed Care - **Event**: BOA Healthcare Conference on May 13, 2025 Key Points Growth and Strategic Focus - Tenet Healthcare is experiencing strong momentum and is focused on growth, capital deployment, and expansion opportunities in accretive service lines [3][4] - The company is prioritizing cost control and has a healthy pipeline of Ambulatory Surgery Center (ASC) opportunities [4] Ambulatory Surgery Center (ASC) Insights - The ASC business has significant growth potential driven by demographic trends and innovation in surgical procedures [7][8] - Tenet is actively migrating to higher acuity procedures in ASCs, which are more competitive and cost-effective compared to traditional inpatient settings [10][12] - Q1 results showed flat same-store volumes, but double-digit growth in high acuity procedures, indicating a successful strategy in managing acuity levels [12][13] Financial Performance - Tenet has consistently outperformed revenue growth guidance, achieving a growth algorithm of 3% to 6% in top-line revenue [14] - The company reported a 9% growth in Q1, with expectations for sustainable growth rates moving forward [18][19] Market Dynamics - The ASC market is not becoming more competitive in terms of asset acquisition, but the landscape is changing with consolidation among Management Services Organizations (MSOs) [22][23] - The company is well-positioned to adapt to changes in the industry, particularly with the consolidation of MSOs and the entry of large medical distributors [23] Regulatory Environment - Recent proposed reconciliation bills in Washington were perceived as less severe than expected, with strong voter sentiment against Medicaid cuts [24][25] - Tenet is focused on maintaining stable relationships with health plans despite policy uncertainties, emphasizing long-term partnerships [51][52] Hospital Business Performance - The hospital segment is seeing strong demand, with a focus on high acuity and specialty care, particularly in rural areas [32][33] - Q1 admissions increased by 2.9%, and the company is managing growth without excessive cost increases [34] Labor and Cost Management - The labor environment is stable, with manageable wage growth and retention metrics [37][38] - Contract labor usage is low, reflecting a stable workforce and effective management of staffing needs [40][41] Pricing and Revenue Outlook - Tenet is experiencing 3% to 5% rate increases from commercial plans, with good visibility into future contracts [45][46] - The company is confident in its ability to negotiate favorable pricing due to its integrated service offerings [47] Capital Deployment and Free Cash Flow - Tenet's balance sheet is strong, with reduced leverage and increased free cash flow, allowing for disciplined capital deployment in share repurchases and M&A [57][58] Additional Insights - The company is not focused on returning to pre-COVID levels but is instead prioritizing current service line priorities and market opportunities [31][32] - Tenet's strategy includes a focus on high acuity procedures and maintaining operational discipline to manage costs effectively [34][36]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2025 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________ to Commission File Number: 1-7293 (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification ...

Financial Data and Key Metrics Changes - The company reported net operating revenues of $5.2 billion and consolidated EBITDA of $1.163 billion, representing a 14% growth over 2024 [5][12] - Adjusted EBITDA margin improved by 320 basis points to 22.3% in Q1 2025 [5][12] - Free cash flow generated in Q1 was $642 million, with $3 billion in cash on hand and no borrowings under the credit facility [15][16] Business Line Data and Key Metrics Changes - USPI generated $456 million in adjusted EBITDA, a 16% increase over Q1 2024, with same facility revenues growing by 6.8% [5][13] - The Hospital segment's adjusted EBITDA grew 12% to $707 million, with same store hospital admissions up 4.4% [6][13] - Revenue per adjusted admission in the Hospital segment increased by 2.8% [6][14] Market Data and Key Metrics Changes - The company experienced a 35% increase in exchange admissions in Q1 2025, with exchange revenues accounting for about 7% of total consolidated revenues [47][48] - The payer mix remained stable, with managed care representing around 70% of net patient revenues [46] Company Strategy and Development Direction - The company plans to invest approximately $250 million annually in M&A opportunities within the ambulatory space [8][21] - There is a focus on expanding capacity and enhancing service offerings in higher acuity areas, while maintaining operational discipline and cost management [11][94] - The company aims to continue share repurchases, particularly at current valuation multiples, leveraging strong cash flow generation [10][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year targets despite not adjusting guidance early in the year [17][18] - The company remains committed to its growth strategy and capital investments, unaffected by current healthcare policy uncertainties [11][94] - Management highlighted the importance of recruiting and retaining staff to support business growth and operational efficiency [42][43] Other Important Information - The company has significantly deleveraged its balance sheet, with a net debt to EBITDA ratio of 3.1 as of March 31, 2025 [10] - The company repurchased 2.6 million shares for $348 million in Q1 2025 [10][16] Q&A Session Summary Question: Guidance and Q1 Performance - Management confirmed no other out-of-period items besides the $40 million Medicaid supplemental revenue [24][26] - The increase in revenue per case was attributed to contracting platform improvements and a shift towards higher acuity services [26][28] Question: USPI Acquisition Pipeline - The acquisition pipeline is healthy, with a goal of deploying $250 million in investments [29][30] Question: Hospital Segment Margins - Management noted operational strength and effective expense management contributed to better-than-expected margins [34][36] Question: Labor Management Initiatives - The focus is on reducing contract labor while improving staff retention and recruitment [42][43] Question: Acuity and Payer Mix - Continued strength in acuity and payer mix was reported, with a 35% increase in exchange admissions [46][47] Question: Supply Chain and Tariffs - The company is actively engaged in managing supply costs and has no significant changes in procurement setups between ambulatory and hospital segments [83][84] Question: Margin Expansion Potential - Management believes there is potential for margin expansion through improved operating discipline and asset utilization [108][110]

Tenet Healthcare (THC) reported $5.22 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.7%. EPS of $4.36 for the same period compares to $3.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $5.14 billion, representing a surprise of +1.64%. The company delivered an EPS surprise of +40.19%, with the consensus EPS estimate being $3.11.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...

Financial Highlights - Consolidated Adjusted EBITDA reached $1.163 billion, exceeding the high end of the first quarter outlook[8] - Consolidated Adjusted EBITDA grew by 14%[8] - Consolidated Adjusted EBITDA margin was 22.3%[8] - Adjusted diluted EPS increased by 35%[8] Ambulatory (USPI) Performance - Adjusted EBITDA grew by 16%[8] - Same-facility revenue grew by 6.8%[10] - Adjusted EBITDA margin was 38.2%[10] - USPI Net Revenue 2025E Midpoint is $4.925 billion, with a CAGR of 14.7% from 2019[18] - USPI Adjusted EBITDA 2025E Midpoint is $1.950 billion, with a CAGR of 13.9% from 2019[19] Hospital Performance - Adjusted EBITDA, excluding divested hospitals, grew by 23%[8] - Same-hospital admissions grew by 4.4%[9] - Adjusted EBITDA margin was 17.5%[9] Full Year 2025 Outlook - Consolidated Adjusted EBITDA is projected to be between $3.975 billion and $4.175 billion[10, 11] - Net operating revenues are expected to be between $20.6 billion and $21.0 billion[11]

Financial Data and Key Metrics Changes - The company reported net operating revenues of $5.2 billion and consolidated EBITDA of $1.163 billion, representing a 14% growth over 2024 [5][12] - Adjusted EBITDA margin improved by 320 basis points to 22.3% in Q1 2025 [5][12] - Free cash flow generated in Q1 was $642 million, with $3 billion in cash on hand and no borrowings under the credit facility [15][16] Business Line Data and Key Metrics Changes - USPI generated $456 million in adjusted EBITDA, a 16% increase over Q1 2024, with same facility revenues growing by 6.8% [5][13] - Hospital segment adjusted EBITDA grew to $707 million, with same store hospital admissions up 4.4% and revenue per adjusted admission increasing by 2.8% [6][14] Market Data and Key Metrics Changes - The company experienced a 35% increase in exchange admissions in Q1 2025, with exchange revenues now accounting for about 7% of total consolidated revenues [47] - The payer mix remained stable, with managed care representing around 70% of net patient revenues [46] Company Strategy and Development Direction - The company plans to invest approximately $250 million annually in M&A opportunities within the ambulatory space [8][21] - There is a focus on expanding capacity and enhancing service offerings in higher acuity areas, while maintaining operational discipline and cost management [11][94] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year targets despite not adjusting guidance early in the year, citing strong fundamentals and operational performance [17][18] - The company remains committed to a deleveraged balance sheet to support capital allocation priorities and shareholder value [10][16] Other Important Information - The company repurchased 2.6 million shares for $348 million in Q1 2025, indicating a strategy to leverage cash flow for share repurchases [10][16] - Management emphasized the importance of maintaining operational discipline and effective cost management to navigate potential economic stresses [11][94] Q&A Session Summary Question: Guidance and Q1 Performance - Management confirmed no other out-of-period items besides the $40 million Medicaid supplemental revenue and highlighted strong revenue per case growth driven by acuity and strategic opportunities [24][26] Question: USPI Acquisition Pipeline - The acquisition pipeline is healthy, with confidence in deploying the $250 million investment goal, and a focus on diversifying service lines [29][30] Question: Hospital Segment Margins - Management noted that operational strength and effective expense management contributed to better-than-expected margins, with no significant outliers affecting performance [34][36] Question: Labor Management Initiatives - The company is focused on recruiting and retaining staff to improve overall labor performance, with a strategy to balance contract labor usage [42][44] Question: Acuity and Payer Mix - Continued strength in acuity and payer mix was reported, with a 35% increase in exchange admissions contributing positively to revenue [46][47] Question: Supply Chain and Tariffs - The company is actively engaged in managing supply costs and has no significant changes in procurement strategies between ambulatory and hospital segments [83][84] Question: Contingency Plans for Policy Changes - Management is prioritizing growth and operational efficiency while monitoring potential policy changes, with contingency planning in place but not currently prioritized [95][96] Question: Total Joint Market Evolution - There is significant potential for growth in the total joint market, with ongoing shifts towards outpatient settings and higher acuity procedures [102][103] Question: Margin Expansion Potential - Management believes there is room for margin expansion through improved operating discipline, better cost structures, and increased asset utilization [108][110]

Core Insights - Tenet Healthcare (THC) reported quarterly earnings of $4.36 per share, exceeding the Zacks Consensus Estimate of $3.11 per share, and showing an increase from $3.22 per share a year ago, resulting in an earnings surprise of 40.19% [1] - The company generated revenues of $5.22 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.64%, although this represents a decline from year-ago revenues of $5.37 billion [2] - Tenet has consistently outperformed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Outlook - The future performance of Tenet's stock will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current consensus EPS estimate for the upcoming quarter is $2.68 on revenues of $5.16 billion, and for the current fiscal year, it is $12.15 on revenues of $20.87 billion [7] Industry Context - The Medical - Hospital industry, to which Tenet belongs, is currently ranked in the top 6% of over 250 Zacks industries, indicating a favorable outlook for stocks within this sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]

Tenet Reports Strong First Quarter 2025 Results DALLAS — April 29, 2025 — Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2025. "We had an excellent start to the year driven by strong same-store revenue growth and operational discipline, resulting in earnings and cash flows well ahead of our expectations," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We continue to expand access to high-quality specialty care as we effe ...

Industry Overview - The Zacks Medical-Hospital industry consists of for-profit hospital companies providing various healthcare services, including acute care, rehabilitation, and psychiatric care [3] - Revenue generation is influenced by inpatient occupancy levels, medical services ordered, and outpatient procedure volumes [3] - Payments for services come from government programs like Medicare and Medicaid, managed care plans, private insurers, and directly from patients [3] Key Trends Shaping the Hospital Industry - Growing patient volumes are driven by the resumption of elective procedures post-pandemic, with the 65+ age group projected to increase from 17.3% in 2022 to 22.8% by 2050 [4] - Health spending is expected to reach $5.3 trillion by 2025, indicating strong demand for healthcare services [4] - Rising costs are a concern, but programs like the Affordable Care Act are anticipated to support continued growth [4] Managing Cost Pressures - Hospitals are facing rising expenses due to increased patient volumes and higher supply, labor, and benefit costs [5] - Strategies to counter these pressures include improving labor productivity, adopting cost-saving technologies, and enhancing operational efficiency [5] - Stabilizing patient volumes and renegotiated supplier contracts are expected to strengthen cost control [5] Embracing the Digital Shift - The healthcare sector is accelerating the adoption of AI, automation, and real-time analytics to enhance patient care and streamline operations [6] - Telehealth and telemedicine have become essential components of modern healthcare delivery, especially post-pandemic [6] Rising M&A Activity - Mergers and acquisitions are a key growth catalyst, with the industry expected to see continued deal activity driven by capacity expansion and efficiency goals [7] - Economic stabilization is likely to boost confidence in consolidation efforts within the fragmented industry [7] Zacks Industry Rank Shows Promise - The Zacks Medical-Hospital industry currently holds a Zacks Industry Rank of 27, placing it in the top 11% of nearly 250 Zacks industries [9] - Positive earnings outlook and revisions indicate optimism about the industry's growth potential [10] Industry Performance - The Zacks Medical-Hospital industry has outperformed the Zacks Medical sector and the S&P 500, gaining 3% year-to-date compared to the sector's 3.3% decline and the S&P 500's 6.4% fall [12] Industry's Current Valuation - The industry trades at a trailing 12-month EV/EBITDA ratio of 7.48X, significantly lower than the S&P 500's 16.31X and the sector's 10.48X [15] - Over the past five years, the industry has seen an EV/EBITDA range of 6.16X to 9.55X, with a median of 7.99X [15] Company Highlights - **Universal Health Services**: Focuses on acute care hospitals and outpatient centers, with growth driven by rising patient days and an expanding care network [18] - **Tenet Healthcare Corporation**: Operates a broad network of hospitals, with strong revenue growth in its Ambulatory Care segment [22] - **HCA Healthcare**: Positioned for growth with rising patient volumes and expansion into telemedicine [26] - **Community Health Systems**: Focuses on telehealth and hospital acquisitions to enhance specialty services and improve cost efficiency [28]

In its upcoming report, Tenet Healthcare (THC) is predicted by Wall Street analysts to post quarterly earnings of $3.11 per share, reflecting a decline of 3.4% compared to the same period last year. Revenues are forecasted to be $5.14 billion, representing a year-over-year decrease of 4.3%. Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their init ...